MGP
IDXX icon

Metis Global Partners’s Idexx Laboratories IDXX Stock Holding History

Metis Global Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Buy
5,149
+73
+1% +$40.9K 0.06% 238
2026
Q1 		$2.85M Sell
5,076
-399
-7% -$256K 0.07% 229
2025
Q4 		$3.7M Sell
5,475
-1
-0% -$681 0.09% 196
2025
Q3 		$3.5M Sell
5,476
-280
-5% -$170K 0.08% 211
2025
Q2 		$3.09M Sell
5,756
-813
-12% -$389K 0.08% 216
2025
Q1 		$2.76M Buy
6,569
+695
+12% +$302K 0.08% 236
2024
Q4 		$2.43M Buy
5,874
+359
+7% +$157K 0.07% 233
2024
Q3 		$2.79M Buy
5,515
+171
+3% +$83.1K 0.09% 206
2024
Q2 		$2.6M Buy
5,344
+290
+6% +$146K 0.09% 192
2024
Q1 		$2.73M Buy
5,054
+45
+0.9% +$24.6K 0.1% 179
2023
Q4 		$2.78M Sell
5,009
-6
-0.1% -$2.82K 0.11% 165
2023
Q3 		$2.19M Buy
5,015
+1,072
+27% +$535K 0.11% 196
2023
Q2 		$1.98M Buy
3,943
+175
+5% +$83.9K 0.11% 197
2023
Q1 		$1.88M Buy
3,768
+740
+24% +$354K 0.12% 176
2022
Q4 		$1.24M Buy
3,028
+1,342
+80% +$521K 0.11% 211
2022
Q3 		$549K Buy
1,686
+208
+14% +$76.4K 0.09% 268
2022
Q2 		$519K Buy
1,478
+136
+10% +$55.5K 0.08% 279
2022
Q1 		$734K Buy
1,342
+599
+81% +$315K 0.09% 205
2021
Q4 		$489K Buy
+743
New +$466K 0.14% 168

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Metis Global Partners's IDXX Position: Q2 2026 in Review

Metis Global Partners increased its Idexx Laboratories (IDXX) stake by 1.4% in Q2 2026, buying an estimated $40.9K and bringing the position to 5,149 shares worth $2.71M. The position accounts for 0.06% of the portfolio, ranked #238.

Metis Global Partners first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.7M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Metis Global Partners held 5,149 shares of Idexx Laboratories worth $2.71M as of Q2 2026.
  • Metis Global Partners bought 73 Idexx Laboratories shares in Q2 2026, an estimated $40.9K.
  • Idexx Laboratories made up 0.06% of Metis Global Partners's portfolio in Q2 2026, its #238 holding.
  • Metis Global Partners first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Idexx Laboratories position peaked at $3.7M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.